The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Honoraria - Bristol-Myers Squibb; MSD; Novartis; Pierre Fabre; Roche
Speakers' Bureau - Bristol-Myers Squibb; MSD; Novartis; Pierre Fabre; Roche
Travel, Accommodations, Expenses - Bristol-Myers Squibb; MSD; Novartis; Pierre Fabre; Roche
 
Travel, Accommodations, Expenses - Bristol-Myers Squibb; MSD; Novartis; Pierre Fabre
Treatment beyond progression with immune checkpoint inhibitors in advanced melanoma.
 
Pawel Sobczuk
Stock and Other Ownership Interests - Celon Pharma
Travel, Accommodations, Expenses - Bristol-Myers Squibb; MSD; Novartis; Pierre Fabre
 
Anna Malgorzata Czarnecka
Honoraria - Bristol-Myers Squibb; MSD; Novartis; Pierre Fabre; Roche
Speakers' Bureau - Bristol-Myers Squibb; MSD; Novartis; Pierre Fabre; Roche
Research Funding - Bristol-Myers Squibb
Travel, Accommodations, Expenses - Bristol-Myers Squibb; MSD; Novartis; Pierre Fabre; Roche
 
Mateusz Spalek
No Relationships to Disclose
 
Pawel Teterycz
Travel, Accommodations, Expenses - Bristol-Myers Squibb; MSD; Novartis; Pierre Fabre
 
Monika Dudzisz-Śledź
No Relationships to Disclose
 
Tomasz Switaj
Honoraria - Bristol-Myers Squibb; MSD; Novartis; Pierre Fabre; Roche
Speakers' Bureau - Bristol-Myers Squibb; MSD; Novartis; Pierre Fabre; Roche
Travel, Accommodations, Expenses - Bristol-Myers Squibb; MSD; Novartis; Pierre Fabre; Roche
 
Pawel Rogala
Honoraria - Bristol-Myers Squibb; MSD; Novartis; Pierre Fabre; Roche
Speakers' Bureau - Bristol-Myers Squibb; MSD; Novartis; Pierre Fabre; Roche
Travel, Accommodations, Expenses - Bristol-Myers Squibb; MSD; Novartis; Pierre Fabre; Roche
 
Joanna Placzke
No Relationships to Disclose
 
Katarzyna Kozak
Honoraria - Bristol-Myers Squibb; MSD; Novartis; Pierre Fabre; Roche
Speakers' Bureau - Bristol-Myers Squibb; MSD; Novartis; Pierre Fabre; Roche
Travel, Accommodations, Expenses - Bristol-Myers Squibb; MSD; Novartis; Pierre Fabre; Roche
 
Aneta Borkowska
No Relationships to Disclose
 
Hanna Kosela-Paterczyk
Honoraria - Bristol-Myers Squibb; MSD; Novartis; Pierre Fabre; Roche
Speakers' Bureau - Bristol-Myers Squibb; MSD; Novartis; Pierre Fabre; Roche
Research Funding - Bristol-Myers Squibb
Travel, Accommodations, Expenses - Bristol-Myers Squibb; MSD; Novartis; Pierre Fabre; Roche
 
Piotr Rutkowski
Honoraria - Bristol-Myers Squibb; Lilly; Merck; MSD; Novartis; Pfizer; Pierre Fabre; Roche; Sanofi; Sanofi
Consulting or Advisory Role - Amgen; Blueprint Medicines; Bristol-Myers Squibb; MSD; Novartis; Pierre Fabre
Speakers' Bureau - Lilly; Novartis; Pfizer
Research Funding - Bristol-Myers Squibb (Inst); Novartis (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Orphan Europe; Pierre Fabre